| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $29.8M | +73.1% |
| SG&A Expense | $23.6M | +107.0% |
| Operating Income | -$52.0M | -81.8% |
| Pre-tax Income | -$48K | -75.4% |
| Income Tax | $0 | — |
| Net Income | -$48.3M | -75.4% |
| EPS (Basic) | -$0.49 | +57.8% |
| EPS (Diluted) | -$0.49 | +57.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $178.8M | +216.5% |
| Short-term Investments | $39.5M | -3.7% |
| Current Assets | $180.1M | +82.9% |
| Total Assets | $181.2M | +83.8% |
| Current Liabilities | $8.3M | +122.3% |
| Total Liabilities | $8.3M | +122.3% |
| Stockholders' Equity | $172.9M | +82.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$27.8M | -45.1% |
| Capital Expenditures | $13K | — |
| Investing Cash Flow | $2.1M | +105.5% |
| Financing Cash Flow | $108.5M | +4.8% |
| Free Cash Flow | -$27.8M | -45.2% |